22
Backers in a recent round
20 added at least one new company in this market. The remainder participated only in companies they had already backed here.
Explore recently active backers ↗MARKET NOTES / 001CHINA / BEIJING / LIFE SCIENCES
LESS GUESSWORK. A BETTER RESEARCH LIST.Life Sciences.
Life Sciences.
Beijing.
Map the capital.
Find your next conversation.
Who backs this market, where they enter, and how recently they have added a new company. A directory built around the questions founders actually ask.
Build your research shortlist ↘Companies are based in Beijing · investors can be based anywhere
Dataset through 22 May 2026 · calculated 14 Sep 2026
01 / THE SHORTLIST LAB
Make the list work for your company.
19 backers based in Beijing are shown by default. Compare up to three.
A CLOSER LOOK AT WHERE
Find investors in your preferred location.
Search a recorded city, country or neighbourhood among the backers of this market.
Five location searches per day. Results use recorded locations; some investors have city-level coverage only.
19 of 86 selected backers · Beijing only
Shows investors whose recorded city is Beijing. Unknown cities are excluded. Market charts cover all investor locations.
Theme filtering selects backers of companies carrying that theme tag. Entry-stage filtering selects backers with an entry at that stage; the two matches may be different companies. Row metrics describe their entire dated Life Sciences history in Beijing.
Your side-by-side comparison
Lead flags and later investments may be incompletely recorded. Repeat counts are not adjusted for time since entry.
| Compare | Investor / recorded location | Companies here | New in 24 months | Median total entry round | Companies backed again | Latest investment |
|---|---|---|---|---|---|---|
| Loading investors… | ||||||
No backers match these filters. Broaden the theme, location, entry stage or activity window.
02 / THE MARKET READActivity is a better starting point
Activity is a better starting point
than a long list of names.
Latest 24 months: after 22 May 2024 through 22 May 2026.
9
Distinct equity rounds
Across 9 companies, versus 37 rounds in the preceding 24 months. Each company round is counted once.
See the recent evidence ↗11.1%
Rounds at Angel, Pre-Seed or Seed
1 of 9 recent rounds. Compare your stage with its own financing range before sizing the ask.
Compare stage ranges ↗87%
Participations were first entries
20 first investor–company relationships out of 23 participations. The other 3 were later rounds together.
Find backers adding companies ↗Build a syndicate beyond the city.
Of 22 recently active backers, 3 have a recorded Beijing location and 12 are based elsewhere. Location is missing for 7. Search by market experience first, then investigate the people and their remit.
Match the whole round to your plan.
Recent Seed rounds have a median size of Undisclosed, across 0 disclosed amounts. That is total company financing. An individual investor’s cheque or available capital is not disclosed here.
03 / EMERGING THEMES
Which themes are gaining share?
Follow financing activity across the company classifications represented in this market.
Latest four complete quarters: 01 Apr 2025–31 Mar 2026 · 3 market rounds, versus 10 in the preceding four quarters.
Deep Tech
+46.7 pp2 of 3 recent rounds (66.7%), versus 2 of 10 (20.0%).
Small sample: 2 rounds across 2 companies. Treat this as a theme to monitor.
Medical Devices
-30.0 pp0 of 3 recent rounds (0.0%), versus 3 of 10 (30.0%).
Small sample: 0 rounds across 0 companies. Treat this as a theme to monitor.
Genomics
-20.0 pp0 of 3 recent rounds (0.0%), versus 2 of 10 (20.0%).
Small sample: 0 rounds across 0 companies. Treat this as a theme to monitor.
Life Sciences Platforms And Tools
+13.3 pp1 of 3 recent rounds (33.3%), versus 2 of 10 (20.0%).
Small sample: 1 rounds across 1 companies. Treat this as a theme to monitor.
SPIKE DETECTION
Look beyond the headline total.
Share of market roundsPrior four-quarter shareDetected spike
Scroll sideways to explore all quarters.
Q1 2026 · 0 of 0 market rounds · 0 companies · —% share. No spike under the published rule.
Select a dot to inspect the exact count and baseline. The partial quarter through 22 May 2026 is shown but cannot trigger a spike.
The theme shift, year by year.
Share of all recorded Life Sciences rounds in Beijing. Each cell also gives its theme-round count.
| Investment theme | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026* |
|---|---|---|---|---|---|---|---|
| 57.6%19 / 33 | 54.6%12 / 22 | 35.5%11 / 31 | 50.0%6 / 12 | 18.2%2 / 11 | 40.0%2 / 5 | —0 / 0 | |
| 24.2%8 / 33 | 4.6%1 / 22 | 19.4%6 / 31 | 8.3%1 / 12 | 27.3%3 / 11 | 0.0%0 / 5 | —0 / 0 | |
| 39.4%13 / 33 | 40.9%9 / 22 | 22.6%7 / 31 | 25.0%3 / 12 | 18.2%2 / 11 | 0.0%0 / 5 | —0 / 0 | |
| 24.2%8 / 33 | 27.3%6 / 22 | 35.5%11 / 31 | 16.7%2 / 12 | 9.1%1 / 11 | 40.0%2 / 5 | —0 / 0 | |
| 15.2%5 / 33 | 27.3%6 / 22 | 3.2%1 / 31 | 16.7%2 / 12 | 18.2%2 / 11 | 40.0%2 / 5 | —0 / 0 | |
| 12.1%4 / 33 | 22.7%5 / 22 | 32.3%10 / 31 | 33.3%4 / 12 | 36.4%4 / 11 | 0.0%0 / 5 | —0 / 0 | |
| 24.2%8 / 33 | 18.2%4 / 22 | 19.4%6 / 31 | 41.7%5 / 12 | 18.2%2 / 11 | 0.0%0 / 5 | —0 / 0 | |
| 21.2%7 / 33 | 22.7%5 / 22 | 6.5%2 / 31 | 33.3%4 / 12 | 18.2%2 / 11 | 60.0%3 / 5 | —0 / 0 |
*2026 is partial. Company themes use the tags available in this dataset, applied to historical rounds; they do not date when a business adopted a technology. Themes overlap, so shares do not add to 100%. Each company round is counted once within a theme. These charts cover investors from all locations; the shortlist keeps its own location filter.
How a spike is detected
A complete quarter is flagged when its theme share is at least 1.75× the share across the preceding four quarters and at least 5 percentage points higher. It must contain at least 3 theme rounds across 3 companies, at least 10 market rounds, and at least 3 theme rounds in the baseline. All four baseline quarters must have market observations. A zero baseline, missing observations or partial quarter cannot produce a flag.
This is a transparent screening rule, not a statistical significance test or a forecast. A higher share can accompany fewer rounds when the wider market contracts; the counts beside the chart make that distinction visible.
04 / THE DEPTH MAP
One appearance, or a pattern?
277 of 352 backers with dated histories appear in just one company. Select a cell to explore the directory.
| Portfolio breadth here | 1 company | 2 companies | 3–5 | 6–10 | 11+ |
|---|---|---|---|---|---|
| Firms & institutions | |||||
| Individual angels |
Circle area increases with backer count. The shortlist includes backers with 2 or more companies in this market, plus other backers active in the latest 24 months. In the 1-company cell, only recently active backers are available to explore. The shortlist’s investor-location filter also applies; select all locations to broaden the results. 2 backers have only undated entries.
05 / ROUND DESIGN
Different stages. Different capital.
Recent equity rounds · 24-month window.
Amounts are in USD.
StageDistinct roundsMedian / middle half
Angel
1
UndisclosedNo disclosed amounts0 disclosed · small sample
Series A
2
UndisclosedNo disclosed amounts0 disclosed · small sample
Series B
2
$25M$19M–$30M2 disclosed · small sample
Series C
2
$78M$59M–$96M2 disclosed · small sample
Series D
2
$48M$38M–$58M2 disclosed · small sample
06 / FOLLOW THE EVIDENCE
The most recent recorded rounds.
Distinct company rounds.
Named backers are shown lead-first.
Developer of AI-driven platform and tools for scientific research and development
$114M total equity round6 named backers
Beijing Artificial Intelligence Industry Investment Fund · Beijing Jingguorui Equity Investment Fund Management · Beijing Medical and Health Industry Investment Fund · Fortune Capital · Lenovo Capital and Incubator Group · +1 more
Provider of engineered cell lines for the discovery of oncology drugs
$35M total equity round3 named backers
BioTrack Capital · China Everbright · E-Town International Investment & Development
Provider of AI-driven biology solutions enabling the acceleration of drug discovery
Undisclosed total equity round2 named backers
Frees Fund · Shunxifund
Developer of AI-based radiology image solutions primarily for cancer diagnosis
$69M total equity round2 named backers
Hangzhou Urban Industrial Fund · Legend Capital
Manufacturer of molecular diagnostic instruments, reagents, and consumables for research
$14M total equity round2 named backers
Taiping Medical Health Fund · Anhui Kunhua Fund
Provider of chemoproteomics platform for small molecule drug discovery
Undisclosed total equity round4 named backers
Cher Ami · Shenzhen Capital Group · EBI Investment · SenseCapital
07 / READING THE ATLAS
What these patterns can tell you.
The market boundary
Recorded equity rounds for companies tagged Life Sciences and located in Beijing. Investor headquarters may be elsewhere. Company sector and location reflect the available company records, not necessarily the location or sector at the investment date.
The time boundary
Data coverage ends 22 May 2026. The latest market round is 24 Dec 2025. There are 5 undated participations, excluded from timing metrics. Activity after the cutoff is unknown.
The relationship boundary
“New” is the first dated relationship between a backer and a company in this market. “Backed again” requires a later dated round together. A first observed entry may follow an earlier unrecorded investment.
The financing boundary
Amounts describe entire equity rounds, not personal cheques, fund capacity or returns. Medians exclude missing and non-positive amounts; the middle half spans the 25th–75th percentiles. A recorded investment does not establish current availability.
Find the businesses
worth a closer look.
Search Beijing Life Sciences companies in Radar. Filter the company directory to explore the businesses behind your market and investor research.
Explore companies in Radar ↗A research dashboard.
Built for your company.
We build customized research dashboards for companies. Tell us which competitors, markets and questions matter to your team, and discuss a dashboard designed around your needs.
Discuss a custom dashboard ↗A customized service from Fliar. Contact us to discuss your requirements.Turn your questions
into deeper research.
Use Fliar Prism to research a company, market or topic, with reports and insights drawn from its research dataset.
Explore Fliar Prism ↗Start with the company or question you want to understand.Calculated 14 Sep 2026 · 86 investor histories to explore